Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.
The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.
Scope of the Report:
Europe's sales volume accounted for the highest market share (28.23%) in 2016, followed by the North America and China.
At present, the manufactures of Pulmonary Function Testing Systems are concentrated in North America, Europe, China and Japan. Europe is the largest production area in the world, which occupied about 31.42% production share in 2016. The global leading players in this market are CareFusion(BD), Schiller, CHEST, COSMED, nSpire Health, NDD MGC Diagnostics, etc.
The Pulmonary Function Testing Systems are mainly used by Hospitals, Physical Examination Center and Physician Groups. The dominant application of Pulmonary Function Testing Systems is Hospitals.
In the last few years, the total number of high-tech Pulmonary Function Testing Systems developed by domestic manufacturers is limited. This shows that the efforts to develop high-tech product in China is not enough, but also shows that the allocation space of domestic Pulmonary Function Testing Systems still need to expand. There is still a big gap compared with the imported Pulmonary Function Testing Systems.
Despite the presence of competition problems, as large demand of high-tech products at home and abroad, many companies began to enter the field of high-tech, emergence of technological advancements, investors are still optimistic about this area, the future will still have more new investment enter the field. But it is suggested that enterprises those have plans to enter this industry have careful analysis of this market and the advantages or disadvantages of themselves.
The worldwide market for Pulmonary Function Testing Systems is expected to grow at a CAGR of roughly 4.3% over the next five years, will reach 430 million US$ in 2024, from 340 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Pulmonary Function Testing Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
CareFusion(BD)
Schiller
CHEST
COSMED
nSpire Health
NDD
MGC Diagnostics
Minato
Ganshorn
AESRI
Morgan Scientific
M&B
Sikeda
RSDQ
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Portable PFT Systems
Complete PFT Systems
Market Segment by Applications, can be divided into
Hospitals
Physical Examination Center
Physician Groups
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pulmonary Function Testing Systems product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pulmonary Function Testing Systems, with price, sales, revenue and global market share of Pulmonary Function Testing Systems in 2017 and 2018.
Chapter 3, the Pulmonary Function Testing Systems competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Function Testing Systems breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Pulmonary Function Testing Systems market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Pulmonary Function Testing Systems sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Summary:
Get latest Market Research Reports on Pulmonary Function Testing Systems . Industry analysis & Market Report on Pulmonary Function Testing Systems is a syndicated market report, published as Global Pulmonary Function Testing Systems Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Pulmonary Function Testing Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.